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Wound complications after infrainguinal bypass
graft procedures may occur in 7% to 44% of
patients.1,2 As much as 50% of these patients may
have deep wound infections with graft involve-
ment.3 This is a serious complication that leads to
the loss of the extremity in up to 79% of the cases,
with hospital mortality rates that approach 22%.4-11
In particular, higher amputation rates are expected
more as a result of deep wound infections that occur
in the calf or the foot than in the more proximal
sites.12 This clinical entity has been encountered
sporadically in the literature, and the treatment is
still not well established.4,8-10,12
The aim of this study was the retrospective eval-
uation of the results of an aggressive treatment of
deep wound infections. This treatment involved
infrapopliteal autogenous vein graft with débride-
ment, with or without the replacement of the infect-
ed part of the vein graft and the immediate muscle
flap coverage of the tissue defect.
MATERIALS AND METHODS
From January 1993 to October 1996, 169 arte-
rial reconstructions to the crural arteries and 172
reconstructions to the pedal arteries were performed
at the Division of Vascular Surgery at Helsinki
University Central Hospital. All operations were
performed as leg salvage procedures for critical
ischemia. Seventy-eight patients (23%) had postop-
erative wound complications. Fifty-eight patients
(17%) had superficial wound complications that cor-
responded to grades I and II in Szilagyi’s classifica-
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Purpose: The purpose of this study was to determine the efficacy of an aggressive man-
agement of infrapopliteal autogenous vein graft infection.
Methods: Among 341 consecutive infrapopliteal autogenous vein bypass grafts performed
at the Helsinki University Central Hospital, 14 patients (4%) had infragenicular wound
infection that involved the vein graft. Six of these patients had graft rupture and bleed-
ing. An extensive débridement was performed in all patients. Seven of the grafts had to
be partially removed and replaced. The wound and the graft immediately were covered
with local muscle flaps in 4 patients and with free muscle flaps in 10 patients. 
Results: One patient died, and another patient underwent above-knee amputation as a
result of a persistent infection and necrosis of the local muscle flap during the 30-day
postoperative period. No graft rupture occurred after the treatment of the infected con-
duit. Graft occlusion occurred in 4 patients who underwent regrafting because of graft
rupture and in 1 patient with an infected intact conduit. One patient underwent ampu-
tation 15 months later because of an uncontrollable infection despite a patent graft and
a functioning flap. At the 1-month, 6-month, 1-year, and 2-year follow-up periods, the
leg salvage rates were 92%, 75%, 55%, and 44%, respectively. At the same intervals, 92%,
92%, 70%, and 70% of the patients survived and 85%, 68%, 34%, and 34% of the patients
were alive without the loss of their legs.
Conclusion: Radical surgical débridement and immediate muscle flap coverage seem to
offer an effective alternative method to preserve an infected infrapopliteal autogenous
vein graft and to achieve leg salvage. Poor results are expected when a regrafting proce-
dure is necessary for the rupture of an infected vein graft. (J Vasc Surg 1998;28:611-6.)
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tion,13 whereas grade III infections (ie, deep wound
infections with necrosis of the skin and underlying
tissue surrounding the graft, graft exposure, or rup-
ture and bleeding) occurred in 20 patients (6%). Of
these patients, 14 (4%) had grade III infections that
involved an autogenous vein graft situated below the
knee. Because proximal autogenous vein graft infec-
tion usually carries a good prognosis for coverage
with local healthy tissue (ie, rotational muscle flap),
which is feasible and highly effective, only those
patients who had infragenicular autogenous vein
graft infection are included in this study.
Seven of the patients were men, and 7 were
women. The mean age was 69 years (range, 55 to 88
years). Six patients had insulin-dependent diabetes,
and 2 had non insulin–dependent diabetes. One
patient with insulin-dependent diabetes had uremia
that necessitated long-term dialysis. Initially, 8
patients had nonhealing ulcers or gangrene at the
forefoot, and 1 had an ulcer at the heel and 1 at the
Achilles’ region. The initial vascular procedure was a
femorocrural bypass graft in 4 cases, a femoropedal
bypass graft in 7, and a popliteopedal bypass graft in
3. An in situ saphenous vein bypass graft procedure
was initially performed in 8 patients and an ex situ
saphenous vein bypass graft was performed in 2
patients. One patient underwent cephalic vein
bypass grafting, and another underwent vein graft-
ing with the segments of the basilic and great and
small saphenous veins. A composite polytetrafluo-
roethylene (PTFE)/saphenous vein graft was used
in 2 patients.
The diagnosis of a graft infection was made on
clinical grounds with the presence of cellulitis,
abscess, open wound, graft exposure, or rupture.
Microbiologic cultures substantiated the clinical sus-
picion of an infection in all cases. Infection was
restricted to the infrapopliteal segment in all but 1
patient, with vein graft involvement also above the
knee. In 6 patients, the graft ruptured—2 at the site
of the distal anastomosis and 4 above the distal anas-
tomosis at the calf. The mean interval period
between the initial procedure and the graft salvage
procedure was 40 days (range, 8 to 122 days).
The infected wounds were excised radically in all
cases, and tissue specimens routinely were obtained
for culture during the graft salvage operation. In 7
patients, the involved part of the vein graft was
removed and an interposition bypass regrafting was
performed. In the patient with above-knee involve-
ment, the resection of the whole graft was necessary.
The bypass graft procedures were performed with 1
or multiple venous segments taken from a remote
source in 6 instances. In 1 patient who bled from the
distal venous part of a composite graft, the interpo-
sition bypass grafting was performed with a 6-mm
PTFE graft because of the absence of any suitable
veins.
In all patients, a local pedicled or free muscle flap
was used to cover the graft and the tissue defect after
the débridement. A bypass regrafting procedure plus
a free muscle flap (Fig 1) was used in 4 instances, a
bypass regrafting plus a local muscle flap procedure
used in 2, a free muscle flap alone used in 6, and a
local muscle flap alone used in 2. At the level of the
proximal third of the leg, the gastrocnemius muscle
was used as a pedicled flap in 2 instances, whereas
the soleus muscle alone was used in 1 case in which
the lesion was in the middle third of the leg. In
another patient, the local muscle transfer procedure
required both the gastrocnemius and soleus muscle
flaps (Fig 2). These 2 types of local muscle flap,
however, are limited in size and demand adequate
perfusion through their intact pedicles. Therefore,
for the management of the lesions of the distal third
of the leg, the ankle and the foot, and for large
defects at any site, microvascular muscle flaps are
usually indicated. Unfortunately, the poor general
conditions of 2 patients at high risk calling for
regional anesthesia contraindicated the free flap
reconstruction and, instead, a pedicled muscle flap
reconstruction was performed despite its suboptimal
perfusion.
The free muscle flap procedures were performed
in the remaining 10 patients, with the rectus abdom-
inis muscle in 5 patients and the latissimus dorsi in
the other 5 patients. The arterial anastomoses of the
free flaps were made end-to-side directly to the
bypass graft, and venous anastomoses were per-
formed end-to-end to a deep system vein with inter-
rupted 7-0 or 8-0 polypropylene sutures and with
4.5 loupe magnification. The transferred muscle
then was covered with a split thickness skin graft.
Late additional vascular procedures were per-
formed in 3 patients because of graft occlusion. One
patient underwent operation for the banding of an
adjuvant arteriovenous fistula, which caused conges-
tive heart failure.
A 250-mg/day dose of acetylsalicylic acid was
administered after surgery. Antibiotics were given
for 3 to 4 weeks according to the culture results,
wound healing, and kidney function. Bed rest with a
slight elevation of the leg was indicated for 7 days
before the start of gradual ambulation. The follow-
up visits took place at 1 and 3 months and every 3
months thereafter. Graft patency was determined
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with direct pulse examination and Doppler derived
ankle/brachial index measurements, and the viabili-
ty of the muscle flaps was assessed clinically. Duplex
scan examinations were performed when needed.
Angiography was performed for 1 patient who was
first seen with signs of flap ischemia and congestive
cardiac failure as a result of an adjuvant arteriove-
nous fistula.
The mean follow-up period was 12 months
(range, 1 to 48 months).
Cumulative leg salvage—success determinated as
a patient alive without the loss of a leg—and survival
rates were calculated by means of life-table analysis.
The analysis of data was facilitated by the use of a
microcomputer database and the statistical software
SPSS for Windows 7.0 (SPSS Inc, Chicago, Ill).
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Fig 1. A, Completion angiogram of distal anastomosis of popliteopedal ex situ vein bypass
graft. B, Eight days later, wound infection and necrosis led to anastomotic rupture and bleed-
ing, which were controlled here temporarily with clamping inflow. C, Wound excised, and
infected distal graft segment removed and replaced with arm vein. D, Wound covered with
microvascular latissimus dorsi muscle flap and split thickness skin graft, here a typical bulky
appearance at 3 weeks. Later the volume of the flap decreased.
RESULTS
The cultures grew 18 different microorganisms
(Table I). Of the species, 50% were gram-negative.
There were 6 patients (43%) with mixed infections.
Three patients (21%) had infections from gram-neg-
ative micro-organisms. However, among the
patients who bled, 83% of the wounds harbored
gram-negative infections.
The mean hospital stay as a result of a graft sal-
vage procedure was 28 days (range, 5 to 82 days).
The mean follow-up period was 16 months (range, 0
to 48 months). All patients but 1 had an immediate
30-day postoperative leg salvage. This patient had an
above-knee amputation because of a persistent infec-
tion and necrosis of the transposed soleus muscle
despite an open graft. Twelve patients had primary
wound healing during the immediate 30-day postop-
erative period. In the same period, 1 patient with a
patent graft died of a myocardial infarction.
No graft ruptures occurred after the treatment of
the infected conduit. Among the patients who
underwent a resection of the graft and interposition
bypass regrafting because of bleeding, graft occlu-
sion occurred in 4 patients. One of those patients
had an immediate occlusion of both the arterial and
the venous microvascular anastomosis, which stayed
patent after the correction. Other graft occlusions
occurred 2, 3, and 8 months after the operation for
the infection.
Among the patients with intact conduits, graft
occlusion occurred in 1 patient 15 months after a graft
salvage operation. One patient underwent amputation
because of an uncontrollable infection, despite a patent
graft and a functioning flap after 4 months.
At the 1-month, 6-month, 1-year, and 2-year
follow-up periods after graft salvage operation, the
leg salvage rates were 92%, 75%, 55%, and 44%,
respectively. At the same intervals, 92%, 92%, 70%,
and 70% of patients survived, and 85%, 68%, 34%,
and 34% were alive without the loss of their legs.
DISCUSSION 
A deep-seated infrainguinal vascular graft infec-
tion is a serious complication that often causes the
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Fig 2. A, Necrotic skin infection involving femoropedal vein graft. After excision, graft was
covered with local soleus and medial gastrocnemius muscle flaps. B, Flaps raised. C, Flaps
replaced. D, Flaps covered with split thickness skin graft.
rupture of the graft.14 A conservative local manage-
ment, the ligation of the bleeding source, and the
removal of the infected graft with or without remote
site reconstruction are the main treatment alterna-
tives. However, in most cases of anastomosis
involvement, graft rupture, or bleeding, amputation
has unfortunately been the only solution.15 Long
subcutaneously placed grafts are particularly at risk.
In fact, if the distal anastomosis is at the pedal or the
ankle area where grafts are superficially located and
the soft tissue cover is thin, wound healing problems
easily are encountered. Little data are available to
effectively manage this problem because no author
has been able to collect a large series and it is diffi-
cult to conduct randomized studies.
The preservation of distal perfusion is important,
but a lack of adequate outflow vessels may preclude
any revascularization procedure.3,11,12 A local
aggressive treatment plus muscle transposition has
been suggested as a highly effective method of cov-
ering infected grafts,12,16 but only a few papers have
dealt with infrapopliteal graft complications.12
Coverage by local muscle transfer often has been
reported in an anedoctal manner,2,4,12 and the use of
free muscle flaps has been reported only once.17 In
our series, we used muscle flap coverage in all
instances because we believe that it brings well-vas-
cularized tissue, eliminates the dead space, and helps
to eradicate the infection, effectively preserving the
bypass graft.18 Some authors10 favor a delayed cov-
erage approach with local treatment followed by
autogenous coverage only when the residual infect-
ed debris is eradicated, the quantitative wound cul-
tures fall below 105 organisms per gram of tissue,
and the wound is granulating. However, delayed
wound coverage may cause the desiccation of the
vein graft and may expose the patient to the risk of
graft rupture.2,10
The use of muscle flaps with split skin coverage
allows wound closure without tension, which is of
major importance in legs with compromised flow
and at risk for residual infection. All but 1 of the
autogenous vein grafts that were treated without any
regrafting procedures were patent during follow-up,
and only 1 patient required an amputation because
of the progression of the infection despite graft
patency and a functioning flap. On the contrary,
among the 6 patients who required a regrafting pro-
cedure because of graft rupture and bleeding, the
functioning muscle flap resulted in immediate pri-
mary wound healing in 5 of the patients. One
patient had secondary healing, but 3 of the patients
underwent further vascular procedures because of
graft occlusion. Local or free muscle flap procedures
may guarantee adequate protection even in the case
of prosthetic bypass regrafting in a clearly infected
field as observed in 1 of our patients who had imme-
diate primary wound healing and whose PTFE inter-
position graft remained patent for 8 months.
Local muscle flaps may have a limited role in the
management of an arterial graft infection in the
infrapopliteal region because they are limited in size
and they are often involved in the infectious process.
Furthermore, their feeding vessels can be affected by
atherosclerosis or damaged during mobilization.
Therefore, the rotational muscle flap should be used
only in patients who are at high-risk and who are not
candidates for a microvascular muscle transfer, which
necessitates a prolonged major operation with gen-
eral anesthesia.
Surgeons must be aware of the seriousness of a
rupture of an infected autogenous vein graft. When
the rupture is not responsible for immediate death
because of exsanguination,9 this condition imposes a
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Table I. Bacteriology of 14 infrapopliteal autoge-
nous vein graft infections
Bacteriology No. of patients
Pseudomonas aeruginosa 8 (5)*
Enterococcus faecalis 7 (3)*
Staphylococci coagulase negative 5
Staphylococcus epidermidis 5 (4)*
Enterobacter cloacae 4 (1)*
Klebsiella pneumoniae 4 (1)*
Diphtheroids 3 (1)*
Staphylococcus aureus 3
Proteus mirabilis 2 (2)*
Bacteroides fragilis 2
Proteus vulgaris 1 (1)*
Streptococcus viridans 1
Acinetobacter 1
Citrobacter freundii 1
Xanthomonas maltophilia 1
Streptococcus pyogenes 1
Candida albicans 1
*Micro-organisms found in patients who bled.
Table II. A suggestion for a modification to the
Szilagyi’s classification13 of graft infections as
appropriate for the determination of infrainguinal
graft outcome
I. Infection affects only the skin
II. Infection extends also into the subcutaneous tissue
III. The graft is infected, and the site of infection is not of
importance
IV. The graft is infected and ruptured
regrafting procedure that, even if limited in its
extension (ie, interposition bypass graft procedure),
often is not followed by graft patency and leg sal-
vage. Our results confirm that wound complications
that are usually classified as grade III infections
according to Szilagyi’s classification12 may present
quite different extensions and gravities. Samson et
al3 proposed a new group III for infections that
included those involving the body of the graft but
not the anastomosis. They regarded deep wound
infections that involved only the anastomosis as
group IV infections, whereas those with anastomot-
ic involvement, septicemia, or anastomotic bleeding
were included in group V. Our results emphasize the
need for consideration of deep-seated graft infec-
tions with and without graft ruptures as 2 different
entities because their outcome appeared to differ
markedly from each other despite an initially suc-
cessful treatment. Actually, we believe that the mus-
cle flaps also may be used effectively in patients with
infected anastomosis with good results and with
those obtained when only the body graft is involved.
On the contrary, patients with graft rupture must be
considered to be at high risk for graft failure and
amputation, and such a serious complication
deserves to be termed as a grade IV wound infection
(Table II). 
CONCLUSION
Although some controversy on the topic exists,
when a surgeon is faced with a deep-seated infection,
radical surgical débridement and immediate muscle
flap coverage seem to offer an effective alternative
method to preserve infected infrapopliteal autoge-
nous vein grafts and to achieve leg salvage. Poor
results are expected when a regrafting procedure is
necessary for the rupture of an infected vein graft.
We gratefully acknowledge the contributions of Anita
Mäkelä, RN, and Jukka Ollgren, MS, in the preparation of
the manuscript.
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